Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia
Abroad (travel likely)RecruitingPHASE4
Conditions
Schizophrenia · Schizoaffective Disorder
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Contact: Principal Investigator (Gary Remington, MD, PhD)Hiroyoshi Takeuchi, MD, PhD (Sub-investigator)Ofer Agid, MD (Sub-investigator)
Study leads
Gary Remington, MD, PhD
Principal Investigator
Centre for Addiction and Mental Health